Dupixent (dupilumab) was the first biologic treatment approved for atopic dermatitis ... you might be able to stop using steroid creams. However, if needed, you can usually combine biologics ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Opens in a new tab or window Once-daily roflumilast cream at 0.15% improved symptoms of atopic dermatitis (AD) across multiple end points. According to investigators of the phase 3 studies that ...

Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.

The FDA has granted Fast Track designation to rezpegaldesleukin for the treatment of moderate to severe atopic dermatitis.

With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

Atopic dermatitis ... These include an injectable biologic medication derived from natural sources and a new non-steroidal topical cream. Additionally, a medication is in development to address ...

A groundbreaking new treatment is EBGLYSS, a biologic therapy which has shown promise in clinical trials for treating moderate to severe atopic dermatitis. EBGLYSS targets specific molecules ...

In atopic eczema these molecules become overactive, which leads to chronic inflammation. Recently, JAK inhibitors—small synthetic molecules—have been introduced which, like biological drugs ...